NBIX
Neurocrine Biosciences Inc.
$138.46
+$1.83(+1.34%)
57
Overall
65
Value
30
Tech
76
Quality
Market Cap
$13.59B
Volume
395.85K
52W Range
$84.23 - $154.61
Target Price
$168.92
EPS Estimates Overview
| Current Quarter | $1.55 | Next Quarter | $1.7 |
| Current Year | $4.41 | Next Year | $6.47 |
| QoQ Growth | +9.7% | YoY Growth | +46.7% |
| 3Y EPS CAGR | +53.0% | Target Price | $168.92 |
| Consensus | Buy | Upside | +22.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $138.46 | +1.3% | 395.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW